Kofman et al., 1993 - Google Patents
Tetracycline derivatives as potential lithium-like compoundsKofman et al., 1993
View PDF- Document ID
- 11047656113009469235
- Author
- Kofman O
- van Embden S
- Belmaker R
- Publication year
- Publication venue
- Lithium in Medicine and Biology
External Links
Snippet
The hypothesis that an imbalance of neuronal cyclic AMP (caMP) is involved in the etiology of bipolar affective disorder was suggested (Wachtel 1988), since lithium markedly inhibits agonist stimulation of cẢMP (Belmaker 1981). This effect may be related to inhibition of …
- 150000001875 compounds 0 title description 5
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dalvi et al. | Experimental induction of chronic aflatoxicosis in chickens by purified aflatoxin B1 and its reversal by activated charcoal, phenobarbital, and reduced glutathione | |
| DE69325998T2 (en) | USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE ACID TO PROMOTE NITROGEN RETENTION IN PEOPLE | |
| DE69927496T2 (en) | PAIN RELIEF WITH ENDOGENIC CANNABINOIDS | |
| DE1792295B1 (en) | Pharmaceutical preparation containing 1-aminomethyladamantane | |
| DE69733089T2 (en) | Treatment of osteotarthritis by administration of poly-N-acetyl-D-glucosamine | |
| Winteringham et al. | Comparative response of insects and mammals to certain halogenated hydrocarbons used as insecticides | |
| Straube et al. | Studies with cysteinamine and cysteine in x-irradiated animals | |
| Robinson et al. | The effect of acetylcholine depletion on behavior following traumatic brain injury | |
| Johnson | Effect of diazepam on food consumption in rats | |
| Pellitteri et al. | The influence of intensive hyperbaric oxygen therapy on skin flap survival in a swine model | |
| DE60005947T2 (en) | COMPOSITIONS FOR MODULATING THE IMMUNE RESPONSE AND TREATING INFLAMMABLE DISEASES | |
| GB2269993A (en) | Nerve gas antidote | |
| Aulerich et al. | Biological effects of epidermal growth factor and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on developmental parameters of neonatal mink | |
| JP3889844B2 (en) | Amyotrophic lateral sclerosis therapeutic agent | |
| Kofman et al. | Tetracycline derivatives as potential lithium-like compounds | |
| EP0658106A1 (en) | Thiol derivates for maintaining and/or increasing muscle strength and body cell mass | |
| Richardson et al. | Intergeneric behavioral differences among methamphetamine treated mice | |
| Trope et al. | Systemic absorption of topically applied chloramphenicol eyedrops. | |
| Raphael et al. | Plasma concentration of gentamicin in turtles | |
| DE2432393C3 (en) | Medicinal preparation for the treatment of malignant neoplasms | |
| Rohse et al. | Absorption of choline from intestinal loops in dogs | |
| Fries et al. | Effect of Microsomal Enzyne Inducing Drugs on DDT and Dieldrin Elimination from Cows | |
| DE69426986T2 (en) | TREATMENT OF LAMINITIS | |
| Javed et al. | Pathological effects of gentamicin in growing broilers | |
| Channa et al. | Preventive role of zinc chloride against toxicity of ciprofloxacin on the growing cartilage of Wistar albino rat litter |